Psödohipoparatiroidi Tip 1A: Olgu Sunumu

Temel Bulgular & Veri:Tip 1A, biyokimyasal özelliklere ek olarak Albright herediter osteodistrofisi (AHO) olarak bilinen karakteristik somatik bir fenotipe de sahiptir.

💡

Sonuç & Katkı:Burada biz, hipokalsemi ve Albright herediter osteodistrofisi tanısı koyduğumuz; kalsiyum, aktif D vitamini ile tedavi ettiğimiz olgumuzu sunduk

🔬Tür:Araştırma Makalesi

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Alan Parametreleri

Özet

Psödohipoparatiroidizm (PHPT); hedef organın parathormona (PTH) yanıt vermediği kalıtımsal bir bozukluktur. Biyokimyasal olarak; hipokalsemi, hiperfosfatemi ve PTH yüksekliği ile karakterizedir. PTH uygulamasına verilen yanıt belirgin derecede düşüktür. Tip 1A, biyokimyasal özelliklere ek olarak Albright herediter osteodistrofisi (AHO) olarak bilinen karakteristik somatik bir fenotipe de sahiptir. Bu fenotipin, kısa boy, yuvarlak yüz, frontal bombelik, brakidaktili, obezite özelikleri bulunmaktadır. Burada biz, hipokalsemi ve Albright herediter osteodistrofisi tanısı koyduğumuz; kalsiyum, aktif D vitamini ile tedavi ettiğimiz olgumuzu sunduk

Abstract

Pseudohypoparathyroidism (PHPT); is a hereditary disorder in which the target organ does not respond to parathormone (PTH). Biochemically; it is characterized by the hypocalcemia, hyperphosphatemia, and elevated PTH. The response to PTH administration is markedly lower. In addition to it's biochemical properties, Type 1A also has a characteristic somatic phenotype known as Albright hereditary osteodystrophy (AHO). This phenotype is characterized by short stature, round face, frontal bubble, brachydactyly, obesity. Here, we present a patient, diagnosed with Albright's hereditary osteodystrophy and hypocalcemia that is treated by calcium, vitamin D

🔖

Bu Makaleye Atıf Yap

GÜVEN, M., PEKKOLAY, Z., SOYLU, H., BALSAK, B. Ö. T., TUZCU, A. K. (2017). Psödohipoparatiroidi Tip 1A: Olgu Sunumu. Dicle Tıp Dergisi, Cilt: 44 - Sayı: 2, 213–217. https://ajindex.com/articles/200321

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (8)

Doyle DA, Digeorge AM. Pseudohypoparathyroidism (Albright hereditary osteodystrophy). In Kliegman RM, Behrman RE, Jenson HB, Stanton BF (eds). Nelson Textbook of Pediatrics, 18th ed. Philadelphia, Saunders Co; 2007; 2344-5.
Goswami M, Verma M, Singh A, et al. Albright hereditary osteodystrophy: a rare case report. J Indian Soc Pedod Prev Dent 2009; 27: 184-8.
Bringhurst FR, Demay MB, Kronenberg HM: Hormones and disorders of mineral metabolism. In: Williams Textbook of Endocrinology. 9th ed. WB Saunders Company, 1998: 1155-1209.
Maeda SS, Fortes EM, Oliveira UM, et al. Hypoparathyroidism and pseudohypoparathyroidism. Arq Bras. Endocrinol Metabol 2006; 50: 664-73.
Weinstein LS, Gejman PV, Friedman E et al. Mutations of the Gs -subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci US A 1990; 87: 8287-90.
Ally MR, Bernet VJ, Atwood JE. Visual vignette. Type 1A pseudohypoparathyroidism. Endocr Pract 2008; 14: 952-3. Levine M. Hypoparathyroidism and pseudohypo- parathyroidism. In: DeGroot LJ, Jameson JL. Endocrinology, 4thed. Philadelphia: WB Saunders, 2001. pp. 1133-53. Spiegel AM. Hypercalcemia and Hypocalcemia. In Wyngaarden JB, Smith LH, BennettJC (eds). The Parathyroid Glands, Philadelphia, Saunders Company 1992: 1418-20. Levine MA. Clinical Review: Pseudohypo- parathyroidism: From bedside to bench and back. J Bone Miner Res 1999; 14: 1255-60.
Sachs C, Sjoberg HE, Ericson K. Basal ganglion calcification onCT:relation to hypopara-thyroidism. Neurology 1982;32:779-82.
Faissolle P, Wagner-Mahler K, Mas JC, at al. A cause of intracerebral calcifications that should be known: pseudohypoparathyroidism 2008;15:1433-6. Ib. Arch Pediatr